Characterization of immunoreactive endothelin in human urine

Area of Science:

• Biochemistry
• Immunology
• Analytical Chemistry

Background:

• Endothelin-1 (ET-1) is a potent vasoconstrictor peptide with significant physiological roles.
• Accurate measurement of ET-1 in biological samples like urine is crucial for understanding its involvement in various diseases.
• Existing methods for ET-1 detection may lack specificity or sensitivity for certain forms.

Purpose of the Study:

• To develop highly specific and sensitive antibodies for endothelin-1 (ET-1).
• To establish reliable enzyme immunoassays (EIAs) for quantifying immunoreactive ET (IR-ET) in human urine.
• To characterize the main component of IR-ET present in human urine.

Main Methods:

• Development of three antibodies specific to ET-1.
• Establishment of two sandwich and three competitive enzyme immunoassays (EIAs).
• Partial purification of large IR-ET from human urine using a six-step procedure.
• Analysis of purified IR-ET by SDS-PAGE and Western blotting under reduced and non-reduced conditions.

Main Results:

• A major component of large immunoreactive ET (IR-ET) with a molecular weight of 10 kDa was identified in human urine.
• This 10 kDa IR-ET reacted with antibodies against the N-terminal region of ET-1 but not with antibodies against the C-terminal peptide.
• Western blotting confirmed the 10 kDa IR-ET as a single band under both reduced and non-reduced conditions, indicating a single polypeptide chain.

Conclusions:

• The developed antibodies and EIAs are effective tools for detecting ET-1 related substances in urine.
• The primary form of IR-ET in human urine is a 10 kDa molecule composed of a single polypeptide chain.
• This 10 kDa IR-ET possesses a sterically restricted N-terminal region of ET-1.